- Home
- TRU vs BAX Comparison
TRU vs BAX Comparison
Compare TRU & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TRU | BAX |
|---|---|---|
| Founded | 1968 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.7B | 13.9B |
| IPO Year | 2013 | 1994 |
Fundamental Metrics
Financial Performance| Metric | TRU | BAX |
|---|---|---|
| Price | $62.88 | $23.35 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 12 | 9 |
| Target Price | ★ $90.73 | $21.00 |
| AVG Volume (30 Days) | 2.1M | ★ 5.8M |
| Earning Date | 04-28-2026 | 04-30-2026 |
| Dividend Yield | ★ 0.71% | 0.24% |
| EPS Growth | ★ 60.00 | N/A |
| EPS | ★ 2.04 | 0.21 |
| Revenue | $4,576,300,000.00 | ★ $11,244,000,000.00 |
| Revenue This Year | $11.20 | $1.96 |
| Revenue Next Year | $8.00 | $2.22 |
| P/E Ratio | ★ $32.45 | $111.43 |
| Revenue Growth | ★ 9.38 | 5.72 |
| 52 Week Low | $63.37 | $15.73 |
| 52 Week High | $89.12 | $30.00 |
Technical Indicators
Market Signals| Indicator | TRU | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 23.41 | 38.70 |
| Support Level | N/A | $22.56 |
| Resistance Level | $74.19 | $23.62 |
| Average True Range (ATR) | 2.24 | 0.65 |
| MACD | -1.22 | -0.02 |
| Stochastic Oscillator | 8.36 | 35.97 |
Price Performance
Historical ComparisonAbout TRU TransUnion
TransUnion, along with Equifax and Experian, is one of the three leading credit bureaus in the United States, providing the consumer information that is the basis for granting credit. The company also provides fraud detection, marketing, and analytical services. TransUnion operates in over 30 countries. About 20%-25% of its revenue comes from international markets.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.